NYSE · Drug Manufacturers - General

Organon & Co (OGN)

$13.75 +0.07%
Add alert
75 Overbought Daily RSI (14) · 21 Aug 2026

Moving averages

SMA 200$9.72+41.46%

Company profile

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, Hormone replacement therapy (HRT), and anesthesia. The company sells to international markets.

SectorHealthcare
IndustryDrug Manufacturers - General
Market cap$3.59B
P/E ratio17.51
EPS$0.78
Beta1.52
Dividend yield0.59%
52-week high$13.72
52-week low$5.68

Similar stocks in Drug Manufacturers - General

PFE Pfizer Inc RSI 72 LLY Lilly(Eli) & Company RSI 60 JNJ Johnson & Johnson RSI 62 BMY Bristol-Myers Squibb Company RSI 63 MRK Merck & Co Inc RSI 78 NVO Novo Nordisk RSI 50 ABBV Abbvie Inc RSI 64 GILD Gilead Sciences Inc RSI 67 AMGN AMGEN Inc RSI 74 GSK GSK Plc RSI 56
Free forever

RSI alerts for OGN

Get an email the moment Organon & Co crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 14 August 2026 at 6:26 AM EDT